Jundishapur Journal of Microbiology

Published by: Kowsar

Distribution of Hepatitis C Virus Genotypes and Related Risk Factors Among Iranian Blood Donors: A Penalized Logistic Regression

Fahimeh Ranjbar Kermani 1 , Sedigheh Amini-Kafiabad 1 , * , Kamran Mousavi Hosseini 1 , Mahtab Maghsudlu 1 , Zohreh Sharifi 1 and Mohammad Ali Mansournia 2
Authors Information
1 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Jundishapur Journal of Microbiology: December 2018, 11 (12); e69136
  • Published Online: November 11, 2018
  • Article Type: Research Article
  • Received: April 7, 2018
  • Revised: October 14, 2018
  • Accepted: October 18, 2018
  • DOI: 10.5812/jjm.69136

To Cite: Ranjbar Kermani F, Amini-Kafiabad S, Mousavi Hosseini K, Maghsudlu M, Sharifi Z, et al. Distribution of Hepatitis C Virus Genotypes and Related Risk Factors Among Iranian Blood Donors: A Penalized Logistic Regression, Jundishapur J Microbiol. 2018 ; 11(12):e69136. doi: 10.5812/jjm.69136.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: Global epidemiology and strategies for control. Clin Microbiol Infect. 2016;22(10):833-8. doi: 10.1016/j.cmi.2016.07.035. [PubMed: 27521803].
  • 2. World Health Organization. Hepatitis C [fact sheet], 2016. Geneva: World Health Organization; 2016.
  • 3. Mirminachi B, Mohammadi Z, Merat S, Neishabouri A, Sharifi AH, Alavian SH, et al. Update on the prevalence of hepatitis C virus infection among Iranian general population: A systematic review and meta-analysis. Hepat Mon. 2017;17(2). e42291. doi: 10.5812/hepatmon.42291.
  • 4. Word Healh Organization. Global status report on blood safety and availability 2016. Geneva: World Health Organization; 2017.
  • 5. Murphy DG, Sablon E, Chamberland J, Fournier E, Dandavino R, Tremblay CL. Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol. 2015;53(3):967-72. doi: 10.1128/JCM.02831-14. [PubMed: 25520447]. [PubMed Central: PMC4390628].
  • 6. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, et al. The origin of hepatitis C virus genotypes. J Gen Virol. 1997;78 ( Pt 2):321-8. doi: 10.1099/0022-1317-78-2-321. [PubMed: 9018053].
  • 7. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824-40. doi: 10.3748/wjg.v22.i34.7824. [PubMed: 27678366]. [PubMed Central: PMC5016383].
  • 8. Afridi SQ, Khan N, Akmal M, Ali S, S A, Bahadar S, et al. Distribution of HCV genotypes and RNA viral load along with hemato-biochemical analysis of HCV patients in Rahim Yar Khan, Okara and Toba Tek Singh districts of Punjab, Pakistan. Hepat Mon. 2017;17(7). e58442. doi: 10.5812/hepatmon.58442.
  • 9. Oral Zeytinli Ü, Muhterem Yücel F, Daldaban Dinçer Ş, Yanilmaz Ö, Aksaray S, Özdil K. Distribution of hepatitis C virus genotypes in the region of İstanbul northern anatolian association of public hospitals. Viral Hepatit Dergisis. 2017;23(2):64. doi: 10.4274/vhd.27146.
  • 10. Ghaderi-Zefrehi H, Gholami-Fesharaki M, Sharafi H, Sadeghi F, Alavian SM. The distribution of hepatitis C virus genotypes in middle eastern countries: A systematic review and meta-analysis. Hepat Mon. 2016;16(9). e40357. doi: 10.5812/hepatmon.40357. [PubMed: 27826320]. [PubMed Central: PMC5097177].
  • 11. Mahmud S, Al-Kanaani Z, Chemaitelly H, Chaabna K, Kouyoumjian SP, Abu-Raddad LJ. Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns. J Med Virol. 2018;90(1):131-41. doi: 10.1002/jmv.24921. [PubMed: 28842995]. [PubMed Central: PMC5724492].
  • 12. Khodabandehloo M, Roshani D. Prevalence of hepatitis C virus genotypes in Iranian patients: A systematic review and meta-analysis. Hepat Mon. 2014;14(11). e22915. doi: 10.5812/hepatmon.22915. [PubMed: 25685164]. [PubMed Central: PMC4310018].
  • 13. Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian SM. Prevalence of hepatitis C virus genotypes among patients in countries of the Eastern Mediterranean regional office of WHO (EMRO): A systematic review and meta-analysis. Hepat Mon. 2016;16(4). e35558. doi: 10.5812/hepatmon.35558. [PubMed: 27274353]. [PubMed Central: PMC4894080].
  • 14. Sharifi Z, Shooshtari MM, Kermani FR. Identification of HCV genotypes in HCV infected blood donors. Indian J Microbiol. 2010;50(3):275-9. doi: 10.1007/s12088-010-0059-0. [PubMed: 23100841]. [PubMed Central: PMC3450055].
  • 15. World Health Organization. Hepatitis C fact sheet. Geneva: World Health Organization; 2018, [updated April 2017]. Available from: www.who.int/mediacentre/factsheets/fs204/en/.
  • 16. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. [PubMed: 25086286].
  • 17. Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, et al. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3. J Viral Hepat. 2015;22(S4):4-20. doi: 10.1111/jvh.12475.
  • 18. Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, et al. Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol. 2008;14(8):1237-43. doi: 10.3748/wjg.14.1237. [PubMed: 18300350]. [PubMed Central: PMC2690672].
  • 19. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 1995;171(6):1607-10. doi: 10.1093/infdis/171.6.1607. [PubMed: 7769300].
  • 20. Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, et al. Epidemiological changes in hepatitis C virus genotypes in France: Evidence in intravenous drug users. J Viral Hepat. 2002;9(1):62-70. [PubMed: 11851904].
  • 21. Elghouzzi MH, Bouchardeau F, Pillonel J, Boiret E, Tirtaine C, Barlet V, et al. Hepatitis C virus: Routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang. 2000;79(3):138-44. doi: 10.1159/000031231. [PubMed: 11111231].
  • 22. Salehi Moghadam F, Mohebbi SR, Hosseini SM, Romani S, Mirtalebi H, Azimzadeh P, et al. Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients. J Med Virol. 2014;86(8):1342-9. doi: 10.1002/jmv.23947. [PubMed: 24838700].
  • 23. Nakano T, Lu L, Liu P, Pybus OG. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis. 2004;190(6):1098-108. doi: 10.1086/422606. [PubMed: 15319860].
  • 24. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962-73. doi: 10.1002/hep.20819. [PubMed: 16149085].
  • 25. Cantaloube JF, Laperche S, Gallian P, Bouchardeau F, de Lamballerie X, de Micco P. Analysis of the 5' noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol. 2006;44(6):2051-6. doi: 10.1128/JCM.02463-05. [PubMed: 16757597]. [PubMed Central: PMC1489428].
  • 26. Laperche S, Lunel F, Izopet J, Alain S, Deny P, Duverlie G, et al. Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study. J Clin Microbiol. 2005;43(2):733-9. doi: 10.1128/JCM.43.2.733-739.2005. [PubMed: 15695672]. [PubMed Central: PMC548094].
  • 27. Rezaei N, Amini-Kafiabad S, Maghsudlu M, Abolghasemi H. Risk factor analysis of hepatitis C virus seropositivity in Iranian blood donors: A case-control study. Transfusion. 2016;56(7):1891-8. doi: 10.1111/trf.13660. [PubMed: 27273657].
  • 28. Kermani FR, Hosseini KM, Kafi-Abad SA, Maghsudlu M, Sharifi Z, Mansournia MA, et al. Update on transmission modes of hepatitis C virus among volunteer Iranian blood donors: Analysis of a matched case-control study by penalized conditional logistic regression. Hepatitis Monthly. 2018;18(10). doi: 10.5812/hepatmon.69395.
  • 29. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods. 2003;109(2):187-93. doi: 10.1016/S0166-0934(03)00070-3. [PubMed: 12711062].
  • 30. Mansournia MA, Geroldinger A, Greenland S, Heinze G. Separation in logistic regression: Causes, consequences, and control. Am J Epidemiol. 2018;187(4):864-70. doi: 10.1093/aje/kwx299. [PubMed: 29020135].
  • 31. Greenland S, Mansournia MA, Altman DG. Sparse data bias: A problem hiding in plain sight. BMJ. 2016;352. i1981. doi: 10.1136/bmj.i1981. [PubMed: 27121591].
  • 32. Greenland S, Mansournia MA. Penalization, bias reduction, and default priors in logistic and related categorical and survival regressions. Stat Med. 2015;34(23):3133-43. doi: 10.1002/sim.6537. [PubMed: 26011599].
  • 33. van de Laar TJ, Koppelman MH, van der Bij AK, Zaaijer HL, Cuijpers HT, van der Poel CL, et al. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands. Transfusion. 2006;46(10):1719-28. doi: 10.1111/j.1537-2995.2006.00961.x. [PubMed: 17002628].
  • 34. Cantaloube JF, Gallian P, Attoui H, Biagini P, De Micco P, de Lamballerie X. Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France. J Clin Microbiol. 2005;43(8):3624-9. doi: 10.1128/JCM.43.8.3624-3629.2005. [PubMed: 16081888]. [PubMed Central: PMC1233931].
  • 35. Dal Molin G, Ansaldi F, Biagi C, D'Agaro P, Comar M, Croce L, et al. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol. 2002;68(3):352-6. doi: 10.1002/jmv.10210. [PubMed: 12226821].
  • 36. Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, et al. Changing HCV genotypes distribution in Poland--relation to source and time of infection. J Clin Virol. 2008;42(2):156-9. doi: 10.1016/j.jcv.2008.02.001. [PubMed: 18353714].
  • 37. Zhou Y, Wang X, Mao Q, Fan Y, Zhu Y, Zhang X, et al. Changes in modes of hepatitis C infection acquisition and genotypes in Southwest China. J Clin Virol. 2009;46(3):230-3. doi: 10.1016/j.jcv.2009.08.003. [PubMed: 19729342].
  • 38. Butt S, Idrees M, Akbar H, ur Rehman I, Awan Z, Afzal S, et al. The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan. Infect Genet Evol. 2010;10(5):595-600. doi: 10.1016/j.meegid.2010.04.012. [PubMed: 20438863].
  • 39. Dias PT, Hahn JA, Delwart E, Edlin B, Martin J, Lum P, et al. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis. 2011;11:208. doi: 10.1186/1471-2334-11-208. [PubMed: 21810243]. [PubMed Central: PMC3199778].
  • 40. Toyoda H, Kumada T, Takaguchi K, Shimada N, Tanaka J. Changes in hepatitis C virus genotype distribution in Japan. Epidemiol Infect. 2014;142(12):2624-8. doi: 10.1017/S0950268814000478. [PubMed: 24598252].
  • 41. Chen W, Liao B, Hu F, Nie J, Lan Y, Li H, et al. Changing epidemiology of hepatitis C virus genotype among patients with human immunodeficiency virus/hepatitis C virus co-infection in China. PLoS One. 2016;11(9). e0161844. doi: 10.1371/journal.pone.0161844. [PubMed: 27603929]. [PubMed Central: PMC5014309].
  • 42. Acero Fernandez D, Ferri Iglesias MJ, Buxo Pujolras M, Lopez Nunez C, Serra Matamala I, Queralt Moles X, et al. Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years. Gastroenterol Hepatol. 2018;41(1):2-11. doi: 10.1016/j.gastrohep.2017.09.004. [PubMed: 29150360].
  • 43. Li W, Xi L, Cai Q, Kang Y, Zeng Q, Ding R, et al. Changes in the distribution of hepatitis C virus genotypes and their association with shifts in transmission routes in Henan, China. J Public Health. 2017;26(2):157-62. doi: 10.1007/s10389-017-0845-9.
  • 44. Hajia M, Amirzargar A, Khedmat H, Shahrokhi N, Farzanehkhah M, Ghorishi S, et al. Genotyping pattern among Iranian HCV positive patients. Iran J Public Health. 2010;39(2):39-44. [PubMed: 23113005]. [PubMed Central: PMC3481755].
  • 45. Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1). doi: 10.5812/hepatmon.7991. [PubMed: 23550108]. [PubMed Central: PMC3582303].
  • 46. Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol. 2015;21(38):10790-810. doi: 10.3748/wjg.v21.i38.10790. [PubMed: 26478671]. [PubMed Central: PMC4600581].
  • 47. Amini S, Mahmoodi Farahani Majd Abadi M, Joulaie M, Ahmadipour M. Distribution of hepatitis C virus genotypes in Iran: A population-based study. Hepat Mon. 2009;9(2):95-102.
  • 48. Mokhtari M, Basirkazeruni H, Rostami M. The correlation between different risk factors of hepatitis C and different genotypes. Adv Biomed Res. 2017;6:45. doi: 10.4103/2277-9175.204588. [PubMed: 28503500]. [PubMed Central: PMC5414405].
  • 49. Farshadpour F, Makvandi M, Samarbafzadeh AR, Jalalifar MA. Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. Indian J Med Microbiol. 2010;28(1):54-6. doi: 10.4103/0255-0857.58731. [PubMed: 20061766].
  • 50. Ranjbar Kermani F, Sharifi Z, Ferdowsian F, Paz Z, Zamanian M. Distribution of hepatitis C virus genotypes among chronic infected injecting drug users in Tehran, Iran. Jundishapur J Microbiol. 2013;6(3):265-8. doi: 10.5812/jjm.5191.
  • 51. Ederth J, Jern C, Norder H, Magnius L, Alm E, Rognsvag BK, et al. Molecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns. Infect Ecol Epidemiol. 2016;6:30670. doi: 10.3402/iee.v6.30670. [PubMed: 26854010]. [PubMed Central: PMC4744866].
  • 52. Samimi-Rad K, Rahimnia R, Sadeghi M, Malekpour SA, Marzban M, Keshvari M, et al. Epidemic history of hepatitis C virus among patients with inherited bleeding disorders in Iran. PLoS One. 2016;11(9). e0162492. doi: 10.1371/journal.pone.0162492. [PubMed: 27611688]. [PubMed Central: PMC5017697].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments